Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpinia officinarum, commonly known as lesser galangal, is a perennial herb belonging to the ginger family (Zingiberaceae), native to Southeast China and cultivated in various parts of Asia. While the rhizome is traditionally and widely used in culinary and ethnomedicine, the leaves of Alpinia officinarum also contain bioactive phytochemicals, including flavonoids like galangin, diarylheptanoids, and volatile oils. Extracts from the leaves have been investigated for various pharmacological activities, supporting their potential use in traditional health practices and as a dietary supplement. The plant has a long history of use in Ayurvedic and Chinese medicine for treating various ailments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alpinia officinarum leaf.